On October 23, Colgate-Palmolive fell 3.11% in Regular Trading, trading at $94.37 per share, with turnover of $71.0135 million.
The main disclosed catalyst was a recent UBS note saying Colgate-Palmolive is expected to report October 30 third-quarter results broadly in line with Street estimates, while full-year guidance is likely to remain unchanged.
UBS said higher input costs could push full-year EPS growth toward the lower end of the existing range, and investor focus is shifting toward the outlook for the following year, including inflation, foreign-exchange pressure, and the pace of North America recovery. That backdrop appears to have weighed on sentiment despite a relatively stable near-term earnings view. Colgate-Palmolive last reported adjusted EPS of $0.99 for the June quarter, above the $0.95 consensus, and the next report is expected to show EPS of $0.92.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments